A Gibson

2.2k total citations · 1 hit paper
50 papers, 1.9k citations indexed

About

A Gibson is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, A Gibson has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 17 papers in Cellular and Molecular Neuroscience and 14 papers in Molecular Biology. Recurrent topics in A Gibson's work include Pain Mechanisms and Treatments (21 papers), Neuropeptides and Animal Physiology (14 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). A Gibson is often cited by papers focused on Pain Mechanisms and Treatments (21 papers), Neuropeptides and Animal Physiology (14 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). A Gibson collaborates with scholars based in United Kingdom, United States and Belgium. A Gibson's co-authors include P.K. Moore, O A Al‐Swayeh, N.W.S. Chong, Rachel A. Evans, Ian McFadzean, C. Wayman, Adrian J. Hobbs, Stephen L. Hart, P Wallace and Peter K. Moore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Trends in Pharmacological Sciences.

In The Last Decade

A Gibson

47 papers receiving 1.8k citations

Hit Papers

l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐revers... 1990 2026 2002 2014 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Gibson United Kingdom 21 1.1k 527 511 402 309 50 1.9k
A.M. Compton United Kingdom 26 1.5k 1.4× 446 0.8× 545 1.1× 855 2.1× 315 1.0× 51 2.2k
P M Vanhoutte United States 21 1.0k 1.0× 664 1.3× 479 0.9× 540 1.3× 149 0.5× 28 2.2k
Kazuhide Ayajiki Japan 28 1.3k 1.2× 487 0.9× 381 0.7× 628 1.6× 287 0.9× 89 2.7k
F H Jordaens Belgium 12 1.1k 1.0× 321 0.6× 371 0.7× 502 1.2× 248 0.8× 16 1.7k
D Jothianandan United States 10 1.8k 1.6× 904 1.7× 490 1.0× 818 2.0× 373 1.2× 11 2.9k
David P. Westfall United States 25 616 0.6× 984 1.9× 684 1.3× 321 0.8× 361 1.2× 71 2.2k
Kunihiko Yokotani Japan 25 419 0.4× 741 1.4× 609 1.2× 219 0.5× 407 1.3× 100 1.7k
Yoshitsugu Osumi Japan 24 433 0.4× 674 1.3× 805 1.6× 187 0.5× 367 1.2× 95 1.8k
Alan Gibson United Kingdom 18 632 0.6× 483 0.9× 340 0.7× 196 0.5× 249 0.8× 34 1.2k
B B Hoffman United States 20 540 0.5× 742 1.4× 416 0.8× 417 1.0× 98 0.3× 32 1.8k

Countries citing papers authored by A Gibson

Since Specialization
Citations

This map shows the geographic impact of A Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Gibson more than expected).

Fields of papers citing papers by A Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Gibson. The network helps show where A Gibson may publish in the future.

Co-authorship network of co-authors of A Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of A Gibson. A scholar is included among the top collaborators of A Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Gibson. A Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Claudia C., Sarah A. Baxter, A Gibson, et al.. (2025). Randomized crossover clinical studies to assess abuse liability and nicotine pharmacokinetics of Velo Oral Nicotine pouches. Frontiers in Pharmacology. 16. 1547073–1547073. 1 indexed citations
2.
Tsoi, E., et al.. (2023). Intrathecal Morphine and Post-Operative Pain Relief in Robotic Surgeries: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(1). 137–137. 2 indexed citations
3.
Wallace, P, et al.. (1999). Thapsigargin-induced tone and capacitative calcium influx in mouse anococcygeus smooth muscle cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 360(4). 368–375. 23 indexed citations
4.
Gibson, A, Ian McFadzean, P Wallace, & C. Wayman. (1998). Discussion. Trends in Pharmacological Sciences. 19(7). 266–269. 141 indexed citations
5.
Wayman, C., A Gibson, & Ian McFadzean. (1997). Depletion of either ryanodine- or IP 3 -sensitive calcium stores activates capacitative calcium entry in mouse anococcygeus smooth muscle cells. Pflügers Archiv - European Journal of Physiology. 435(2). 231–239. 40 indexed citations
6.
Gibson, A, et al.. (1994). Nitrergic stimulation does not inhibit carbachol-induced inositol phosphate generation in the rat anococcygeus. Neuroscience Letters. 178(1). 35–38. 6 indexed citations
7.
Gibson, A, Ian McFadzean, John F. Tucker, & C. Wayman. (1994). Variable potency of nitrergic‐nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone. British Journal of Pharmacology. 113(4). 1494–1500. 37 indexed citations
8.
Brave, Sandra R., John F. Tucker, A Gibson, et al.. (1993). Localisation of nitric oxide synthase within non-adrenergic, non-cholinergic nerves in the mouse anococcygeus. Neuroscience Letters. 161(1). 93–96. 18 indexed citations
9.
Gibson, A, R.C. Babbedge, Sandra R. Brave, et al.. (1992). An investigation of some S‐nitrosothiols, and of hydroxy‐arginine, on the mouse anococcygeus. British Journal of Pharmacology. 107(3). 715–721. 64 indexed citations
10.
Gibson, A, et al.. (1990). l‐NG‐monomethyl arginine andl‐NG‐nitro arginine inhibit non‐adrenergic, non‐cholinergic relaxation of the mouse anococcygeus muscle. British Journal of Pharmacology. 99(3). 602–606. 178 indexed citations
11.
Moore, P.K., O A Al‐Swayeh, N.W.S. Chong, Rachel A. Evans, & A Gibson. (1990). l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro. British Journal of Pharmacology. 99(2). 408–412. 683 indexed citations breakdown →
12.
Gibson, A, et al.. (1990). L-NG-nitroarginine is a potent inhibitor of non-adrenergic, non-cholinergic relaxations in the rat anococcygeus muscle. European Journal of Pharmacology. 183(5). 1793–1793.
14.
Gibson, A, et al.. (1989). The effect of Ca deprivation and of Ca-blocking drugs on oxytocin-induced contractions of the male mouse anococcygeus. Journal of Pharmacy and Pharmacology. 41(6). 412–415. 1 indexed citations
15.
Gibson, A, et al.. (1988). Agonist profile of ergometrine (ergonovine) on a population of postsynaptic α-adrenoceptors. Journal of Pharmacy and Pharmacology. 40(2). 137–139. 3 indexed citations
16.
Gibson, A. (1986). An oxytocin receptor in anococcygeus muscles isolated from male mice. British Journal of Pharmacology. 88(1). 155–159. 4 indexed citations
17.
Gibson, A. (1981). THE INFLUENCE OF ENDOCRINE HORMONES ON THE AUTONOMIC NERVOUS SYSTEM. Journal of Autonomic Pharmacology. 1(4). 331–358. 30 indexed citations
18.
Henderson, A. H., et al.. (1979). BETA-BLOCKER WITHDRAWAL SYNDROME. The Lancet. 313(8121). 875–876. 6 indexed citations
19.
Gibson, A, et al.. (1977). The effect of some dopamine agonists and antagonists on the rat anococcygeus muscle in vitro [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(3). 471P–472P. 3 indexed citations
20.
Gibson, A, et al.. (1977). Tissue variability and some properties of the accumulation of [3H]-corticosterone by isolated organs [proceedings].. PubMed. 61(1). 122P–123P.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026